Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
    • COVID-19
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • CHEST 2021
    • IDWeek 2021
    • IAS 2021
    • ADA 2021
    • ATS 2021
    • ACC 2021
    • ACP 2021
    • AAN 2021
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
    • COVID-19
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • CHEST 2021
    • IDWeek 2021
    • IAS 2021
    • ADA 2021
    • ATS 2021
    • ACC 2021
    • ACP 2021
    • AAN 2021

Index by author

December 01, 2019; Volume 86,Issue 12
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Aronow, Benjamin

    1. You have access
      Gabapentin for alcohol use disorder: A good option, or cause for concern?
      Vania Modesto-Lowe, MD, MPH, Gregory C. Barron, MD, Benjamin Aronow, BS and Margaret Chaplin, MD
      Cleveland Clinic Journal of Medicine December 2019, 86 (12) 815-823; DOI: https://doi.org/10.3949/ccjm.86a.18128

      There is concern about the potential for abuse. Use it only as a second-line alternative, with caution.

  2. Azmaiparashvili, Zurab

    1. You have access
      Desquamating pustular rash
      Kevin Bryan Uy Lo, MD and Zurab Azmaiparashvili, MD
      Cleveland Clinic Journal of Medicine December 2019, 86 (12) 780-781; DOI: https://doi.org/10.3949/ccjm.86a.19061

      The symptoms had started 3 days after the patient began using ciprofl oxacin eye drops.

B

  1. Barron, Gregory C.

    1. You have access
      Gabapentin for alcohol use disorder: A good option, or cause for concern?
      Vania Modesto-Lowe, MD, MPH, Gregory C. Barron, MD, Benjamin Aronow, BS and Margaret Chaplin, MD
      Cleveland Clinic Journal of Medicine December 2019, 86 (12) 815-823; DOI: https://doi.org/10.3949/ccjm.86a.18128

      There is concern about the potential for abuse. Use it only as a second-line alternative, with caution.

  2. Burke, Carol A.

    1. You have access
      In reply: The authors reply
      Carol A. Burke, MD, Gautam Mankaney, MD and Richard Andrew Sutton, DO
      Cleveland Clinic Journal of Medicine December 2019, 86 (12) 776-777; DOI: https://doi.org/10.3949/ccjm.86c.12003

C

  1. Cetel, Nancy S.

    1. You have access
      Colorectal cancer screening
      Joseph B. Weiss, MD, Nancy S. Cetel, MD and Danielle E. Weiss, MD
      Cleveland Clinic Journal of Medicine December 2019, 86 (12) 774-776; DOI: https://doi.org/10.3949/ccjm.86c.12002
  2. Chaplin, Margaret

    1. You have access
      Gabapentin for alcohol use disorder: A good option, or cause for concern?
      Vania Modesto-Lowe, MD, MPH, Gregory C. Barron, MD, Benjamin Aronow, BS and Margaret Chaplin, MD
      Cleveland Clinic Journal of Medicine December 2019, 86 (12) 815-823; DOI: https://doi.org/10.3949/ccjm.86a.18128

      There is concern about the potential for abuse. Use it only as a second-line alternative, with caution.

D

  1. Dinardo, Perry

    1. You have access
      Vaping: The new wave of nicotine addiction
      Perry Dinardo, BA and Ellen S. Rome, MD, MPH
      Cleveland Clinic Journal of Medicine December 2019, 86 (12) 789-798; DOI: https://doi.org/10.3949/ccjm.86a.19118

      Despite perceptions that vaping is harmless and claims that it can aid in smoking cessation, risks are emerging.

G

  1. Gabbard, Scott

    1. Functional heartburn: An underrecognized cause of PPI-refractory symptoms
      You have access
      Functional heartburn: An underrecognized cause of PPI-refractory symptoms
      Scott Gabbard, MD and Sonya Vijayvargiya,
      Cleveland Clinic Journal of Medicine December 2019, 86 (12) 799-806; DOI: https://doi.org/10.3949/ccjm.86a.19006

      Functional heartburn is the most common cause of failure of proton pump inhibitor therapy.

  2. Goldstein, Mark R.

    1. You have access
      Colorectal cancer screening
      Mark R. Goldstein, MD, FACP, Luca Mascitelli, MD and Zakia H. Rauf, MD
      Cleveland Clinic Journal of Medicine December 2019, 86 (12) 774; DOI: https://doi.org/10.3949/ccjm.86c.12001

J

  1. Jimenez, Xavier F.

    1. You have access
      Beyond depression: Other uses for tricyclic antidepressants
      Joanne Schneider, DNP, RN, CNP, Mary Patterson, CNP and Xavier F. Jimenez, MD, MA
      Cleveland Clinic Journal of Medicine December 2019, 86 (12) 807-814; DOI: https://doi.org/10.3949/ccjm.86a.19005

      The pharmacology of these drugs, their potential uses in conditions other than depression, and safety considerations.

L

  1. Lo, Kevin Bryan Uy

    1. You have access
      Desquamating pustular rash
      Kevin Bryan Uy Lo, MD and Zurab Azmaiparashvili, MD
      Cleveland Clinic Journal of Medicine December 2019, 86 (12) 780-781; DOI: https://doi.org/10.3949/ccjm.86a.19061

      The symptoms had started 3 days after the patient began using ciprofl oxacin eye drops.

M

  1. Mandell, Brian F.

    1. You have access
      Off-label and oft-prescribed
      Brian F. Mandell, MD, PhD
      Cleveland Clinic Journal of Medicine December 2019, 86 (12) 766-767; DOI: https://doi.org/10.3949/ccjm.86b.12019

      When prescribing drugs for uses beyond their FDA indications, we need to explain their anticipated side effects and benefits.

  2. Mankaney, Gautam

    1. You have access
      In reply: The authors reply
      Carol A. Burke, MD, Gautam Mankaney, MD and Richard Andrew Sutton, DO
      Cleveland Clinic Journal of Medicine December 2019, 86 (12) 776-777; DOI: https://doi.org/10.3949/ccjm.86c.12003
  3. Mascitelli, Luca

    1. You have access
      Colorectal cancer screening
      Mark R. Goldstein, MD, FACP, Luca Mascitelli, MD and Zakia H. Rauf, MD
      Cleveland Clinic Journal of Medicine December 2019, 86 (12) 774; DOI: https://doi.org/10.3949/ccjm.86c.12001
  4. Modesto-Lowe, Vania

    1. You have access
      Gabapentin for alcohol use disorder: A good option, or cause for concern?
      Vania Modesto-Lowe, MD, MPH, Gregory C. Barron, MD, Benjamin Aronow, BS and Margaret Chaplin, MD
      Cleveland Clinic Journal of Medicine December 2019, 86 (12) 815-823; DOI: https://doi.org/10.3949/ccjm.86a.18128

      There is concern about the potential for abuse. Use it only as a second-line alternative, with caution.

  5. Mossad, Sherif Beniameen

    1. You have access
      How to respond to flu vaccine doubters
      Sherif Beniameen Mossad, MD, FACP, FIDSA, FAST
      Cleveland Clinic Journal of Medicine December 2019, 86 (12) 782-788; DOI: https://doi.org/10.3949/ccjm.86a.19139

      Misinformation and unfounded fears abound. What should you tell patients who say no to a fl u shot?

P

  1. Patterson, Mary

    1. You have access
      Beyond depression: Other uses for tricyclic antidepressants
      Joanne Schneider, DNP, RN, CNP, Mary Patterson, CNP and Xavier F. Jimenez, MD, MA
      Cleveland Clinic Journal of Medicine December 2019, 86 (12) 807-814; DOI: https://doi.org/10.3949/ccjm.86a.19005

      The pharmacology of these drugs, their potential uses in conditions other than depression, and safety considerations.

R

  1. Rauf, Zakia H.

    1. You have access
      Colorectal cancer screening
      Mark R. Goldstein, MD, FACP, Luca Mascitelli, MD and Zakia H. Rauf, MD
      Cleveland Clinic Journal of Medicine December 2019, 86 (12) 774; DOI: https://doi.org/10.3949/ccjm.86c.12001
  2. Rome, Ellen S.

    1. You have access
      Vaping: The new wave of nicotine addiction
      Perry Dinardo, BA and Ellen S. Rome, MD, MPH
      Cleveland Clinic Journal of Medicine December 2019, 86 (12) 789-798; DOI: https://doi.org/10.3949/ccjm.86a.19118

      Despite perceptions that vaping is harmless and claims that it can aid in smoking cessation, risks are emerging.

S

  1. Schneider, Joanne

    1. You have access
      Beyond depression: Other uses for tricyclic antidepressants
      Joanne Schneider, DNP, RN, CNP, Mary Patterson, CNP and Xavier F. Jimenez, MD, MA
      Cleveland Clinic Journal of Medicine December 2019, 86 (12) 807-814; DOI: https://doi.org/10.3949/ccjm.86a.19005

      The pharmacology of these drugs, their potential uses in conditions other than depression, and safety considerations.

  2. Sutton, Richard Andrew

    1. You have access
      In reply: The authors reply
      Carol A. Burke, MD, Gautam Mankaney, MD and Richard Andrew Sutton, DO
      Cleveland Clinic Journal of Medicine December 2019, 86 (12) 776-777; DOI: https://doi.org/10.3949/ccjm.86c.12003

V

  1. Vijayvargiya, Sonya

    1. Functional heartburn: An underrecognized cause of PPI-refractory symptoms
      You have access
      Functional heartburn: An underrecognized cause of PPI-refractory symptoms
      Scott Gabbard, MD and Sonya Vijayvargiya,
      Cleveland Clinic Journal of Medicine December 2019, 86 (12) 799-806; DOI: https://doi.org/10.3949/ccjm.86a.19006

      Functional heartburn is the most common cause of failure of proton pump inhibitor therapy.

W

  1. Weiss, Danielle E.

    1. You have access
      Colorectal cancer screening
      Joseph B. Weiss, MD, Nancy S. Cetel, MD and Danielle E. Weiss, MD
      Cleveland Clinic Journal of Medicine December 2019, 86 (12) 774-776; DOI: https://doi.org/10.3949/ccjm.86c.12002
  2. Weiss, Joseph B.

    1. You have access
      Colorectal cancer screening
      Joseph B. Weiss, MD, Nancy S. Cetel, MD and Danielle E. Weiss, MD
      Cleveland Clinic Journal of Medicine December 2019, 86 (12) 774-776; DOI: https://doi.org/10.3949/ccjm.86c.12002
Back to top
PreviousNext

In this issue

Cleveland Clinic Journal of Medicine: 86 (12)
Cleveland Clinic Journal of Medicine
Vol. 86, Issue 12
1 Dec 2019
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author

Issue highlights

  • How to respond to flu vaccine doubters
  • Desquamating pustular rash
  • Colorectal cancer screening
  • Vaping: The new wave of nicotine addiction
Sign up for alerts
  • Editor's Picks
  • Most Cited
  • Most Read
Loading
Hampton hump in acute pulmonary embolism
A brownish erythematous patch in the nipple-areola complex
The underappreciated role of documentation in improving COPD care
Oral hyperpigmentation with weakness and salt-craving
Glycemic targets in the ICU: A look back, and ahead
Unilateral pulmonary edema
Does my patient need an allergy evaluation for penicillin allergy?
Hypertrichosis and topical corticosteroid use
Recurrent anemia in a patient with chronic lymphocytic leukemia
Megaloblastic anemia due to severe vitamin B12 deficiency
Discontinuing antidepressants: Pearls and pitfalls

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2022 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire